Full TitleResponses to Genetic Risk Modifier Testing Among Women with BRCA1/2 Mutations
Women with a mutation in the BRCA1 or BRCA2 genes are at increased risk for hereditary breast and ovarian cancer. However, the cancer risk estimates for these gene mutations are currently wide-ranging and non-specific. A new form of genetic testing, called “genetic risk modifier testing,” may give women with BRCA1/2 gene mutations more specific estimates of their risk of developing breast cancer.
Genetic risk modifier testing is a new form of genetic testing that is not a routine part of clinical care. The purpose of this study is to describe how women with BRCA1/2 mutations react to genetic risk modifier testing and to examine how they make decisions about their health care. Participants will provide a saliva sample for genetic risk modifier testing, receive an updated cancer risk assessment, and complete three questionnaires.
This study is for women age 25 and older who have BRCA1/2 mutations and have not been diagnosed with breast cancer nor had a prophylactic mastectomy. Participants must be able to speak and understand English to complete the questionnaires.
For more information about this study, please email Dr. Jada Hamilton at [email protected].